IP Library › Granted Patent US 12,193,470
Granted Patent B2
US 12,193,470 · App. 18/062,832 · Granted Jan 14, 2025

Oral tobacco product

Inventors: Feng Gao (Midlothian, VA); Frank Scott Atchley (Midlothian, VA); Gregory James Griscik (Midlothian, VA); Christopher Joseph Dinovi (Ruther Glen, VA); Phillip M. Hulan (Midlothian, VA); Diane L. Gee (Chesterfield, VA); Munmaya K. Mishra (Manakin Sabot, VA); James Arthur Strickland (Richmond, VA)
Assignee: Altria Client Services LLC
A24B13/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,193,470
App. No.
18/062,832
Granted
Jan 14, 2025
Kind
B2
Abstract

An oral tobacco product includes a body that is wholly receivable in an oral cavity. The body includes a mouth-stable polymer matrix and tobacco fibers embedded in the mouth-stable polymer matrix. The oral tobacco product can be formed by extruding a mixture of mouth-stable polymer and tobacco fibers.

Claims (36)

1. An oral product, comprising:

a body having a compressibility at 425 N ranging from 60% to 98% and a springiness of greater than 20%, the body including,

a mouth-stable polymer matrix including a mouth-stable polymer in an amount greater than or equal to 40 weight percent of the body;

tobacco embedded in the mouth-stable polymer matrix;

medium chain triglycerides;

a sweetener; and

a flavorant in an amount of less than 20 weight percent.

2. The oral product of claim 1 , wherein

the body further includes a fiber-polymer matrix including,

the mouth-stable polymer matrix, and

the tobacco, and

the fiber-polymer matrix is porous.

3. The oral product of claim 2 , wherein

the fiber-polymer matrix defines a first plurality of pores having a first diameter, the first diameter ranging from 40 microns to 60 microns, and

the fiber-polymer matrix defines a second plurality of pores having a second diameter, the second diameter ranging from 1 micron to 10 microns.

4. The oral product of claim 2 , wherein the fiber-polymer matrix is an extruded fiber-polymer matrix.

5. The oral product of claim 1 , wherein the mouth-stable polymer includes polyurethane, silicon polymer, polyester, polyacrylate, polyethylene, poly(styrene-ethylene-butylene-styrene), poly(styrene-butadiene-styrene), poly(styrene-isoprene-styrene), any copolymer thereof, or any combination thereof.

6. The oral product of claim 1 , wherein the mouth-stable polymer includes polyurethane.

7. The oral product of claim 1 , wherein the body includes the mouth-stable polymer in an amount of greater than 60 weight percent.

8. The oral product of claim 1 , wherein the medium chain triglycerides are present in an amount ranging less than 20 weight percent.

9. The oral product of claim 1 , wherein the sweetener includes saccharine, sucralose, aspartame, acesulfame potassium, or any combination thereof.

10. The oral product of claim 1 wherein the sweetener includes sucrose, honey, glucose, molasses, corn syrup, fructose, lactose, maltose, sorghum syrup, mannitol, sorbitol, fruit juice concentrate, or any combination thereof.

11. The oral product of claim 1 , further comprising:

nicotine, a nicotine derivative, or a combination of nicotine and a nicotine derivative.

12. The oral product of claim 1 , wherein

the tobacco is in the form of tobacco fibers, and

the body defines channels adjacent to the tobacco fibers.

13. The oral product of claim 1 , wherein the springiness ranges from 75% to 95%.

14. The oral product of claim 1 , wherein the body further includes an antioxidant.

15. The oral product of claim 14 , wherein the antioxidant is present in an amount ranging from 0.01 weight percent to 5.0 weight percent.

16. The oral product of claim 14 , wherein the antioxidant includes ascorbyl palmitate, BHT, ascorbic acid, sodium ascorbate, monosterol citrate, tocopherols, propyl gallate, tertiary butylhydroquinone (TBHQ), butylated hydroxyanisole (BHA), Vitamin E, or any combination thereof.

17. The oral product of claim 1 , wherein the body further includes a filler.

18. The oral product of claim 17 , wherein the filler includes starch, di-calcium phosphate, lactose, sorbitol, mannitol, microcrystalline cellulose, calcium carbonate, dicalcium phosphate, calcium sulfate, clays, silica, glass particles, sodium lauryl sulfate, glyceryl palmitostearate, sodium benzoate, sodium stearyl fumarate, talc, a stearate, a wax, a stabilizers, a disintegrating agent, a pH stabilizers, a preservative, or any combination thereof.

19. The oral product of claim 17 , wherein the body includes the filler in an amount ranging less than 10 weight percent.

20. The oral product of claim 1 , further comprising:

a coating on the body.

Continuity (5)
Continuation 16808844 · Mar 4, 2020
Continuation 15816814 · Nov 17, 2017
Continuation 13745073 · Jan 18, 2013
Provisional Application 61588851 · Jan 20, 2012
Related Publication 20230094995A1 · Mar 30, 2023
References Cited (212)
US 1977059A · Hatherell · 1934 [cited by applicant]
US 2162738A · McCoy · 1939 [cited by applicant]
US 3139436A · Bicking · 1964 [cited by applicant]
US 3396735A · Von Bethmann et al. · 1968 [cited by applicant]
US 4153063A · Roselius et al. · 1979 [cited by applicant]
US 4241090A · Stroz et al. · 1980 [cited by applicant]
US 4448208A · Friedrich et al. · 1984 [cited by applicant]
US 4516590A · Teng · 1985 [cited by applicant]
US 4528993A · Sensabaugh, Jr. et al. · 1985 [cited by applicant]
US 4660577A · Sensabaugh et al. · 1987 [cited by applicant]
US 4848373A · Lenkey · 1989 [cited by applicant]
US 4983405A · Cherukuri et al. · 1991 [cited by applicant]
US 4987907A · Townend · 1991 [cited by applicant]
US 5144967A · Cartwright et al. · 1992 [cited by applicant]
US 5372149A · Roth et al. · 1994 [cited by applicant]
US 5417229A · Summers et al. · 1995 [cited by applicant]
US 5487792A · King et al. · 1996 [cited by applicant]
US 5656284A · Balkin · 1997 [cited by applicant]
US 5733574A · Dam · 1998 [cited by applicant]
US 5906811A · Hersh · 1999 [cited by applicant]
US 6110495A · Dam · 2000 [cited by applicant]
US 7798151B2 · Krukonis et al. · 2010 [cited by applicant]
US 9872516B2 · Gao et al. · 2018 [cited by applicant]
US 9884015B2 · Gao et al. · 2018 [cited by applicant]
US 9930909B2 · Gao et al. · 2018 [cited by applicant]
US 10602768B2 · Gao et al. · 2020 [cited by applicant]
US 11517566B2 · Gao et al. · 2022 [cited by applicant]
US 20040101543A1 · Liu et al. · 2004 [cited by applicant]
US 20040118422A1 · Lundin et al. · 2004 [cited by applicant]
US 20040123873A1 · Calandro et al. · 2004 [cited by applicant]
US 20040151771A1 · Gin et al. · 2004 [cited by applicant]
US 20040247669A1 · Gin et al. · 2004 [cited by applicant]
US 20050046363A1 · Yamamoto · 2005 [cited by applicant]
US 20050053665A1 · Ek et al. · 2005 [cited by applicant]
US 20050152971A1 · Rinker et al. · 2005 [cited by applicant]
US 20050178398A1 · Breslin et al. · 2005 [cited by applicant]
US 20050241658A1 · Pera · 2005 [cited by applicant]
US 20050244521A1 · Strickland et al. · 2005 [cited by applicant]
US 20060112965A1 · Whalen · 2006 [cited by applicant]
US 20060185684A1 · Albino et al. · 2006 [cited by applicant]
US 20060191548A1 · Strickland et al. · 2006 [cited by applicant]
US 20070283974A1 · May · 2007 [cited by applicant]
US 20080063609A1 · Nissen · 2008 [cited by applicant]
US 20080124283A1 · Andersen · 2008 [cited by applicant]
US 20080202536A1 · Torrence et al. · 2008 [cited by applicant]
US 20080209586A1 · Nielsen et al. · 2008 [cited by applicant]
US 20080248017A1 · Ron et al. · 2008 [cited by applicant]
US 20080286409A1 · Topsoe et al. · 2008 [cited by applicant]
US 20080317911A1 · Schleef et al. · 2008 [cited by applicant]
US 20090133703A1 · Strickland et al. · 2009 [cited by applicant]
US 20090214445A1 · Boghani et al. · 2009 [cited by applicant]
US 20090293889A1 · Kumar et al. · 2009 [cited by applicant]
US 20090293895A1 · Axelsson et al. · 2009 [cited by applicant]
US 20100061940A1 · Axelsson et al. · 2010 [cited by applicant]
US 20100068270A1 · Turchetta et al. · 2010 [cited by applicant]
US 20100163062A1 · Atchley et al. · 2010 [cited by applicant]
US 20100170522A1 · Sun et al. · 2010 [cited by applicant]
US 20100247594A1 · Kuzma et al. · 2010 [cited by applicant]
US 20100247612A1 · Fuisz · 2010 [cited by applicant]
US 20110053866A1 · Duffield et al. · 2011 [cited by applicant]
US 20110083688A1 · Mishra et al. · 2011 [cited by applicant]
US 20110139164A1 · Mua et al. · 2011 [cited by applicant]
US 20110139166A1 · Luzenberg, Jr. · 2011 [cited by applicant]
US 20110149904A1 · Fong et al. · 2011 [cited by applicant]
US 20110236442A1 · Miser et al. · 2011 [cited by applicant]
US 20110274628A1 · Borschke · 2011 [cited by applicant]
US 20110287681A1 · DeVall · 2011 [cited by applicant]
US 20120031415A1 · Essen et al. · 2012 [cited by applicant]
US 20120167901A1 · Onno et al. · 2012 [cited by applicant]
US 20120318287A1 · Andersen · 2012 [cited by applicant]
US 20130053603A1 · Norstrom et al. · 2013 [cited by applicant]
US 20130074855A1 · Holton, Jr. · 2013 [cited by applicant]
US 20130186416A1 · Gao et al. · 2013 [cited by applicant]
US 20130186417A1 · Gao et al. · 2013 [cited by applicant]
US 20130186418A1 · Gao et al. · 2013 [cited by applicant]
US 20130186419A1 · Gao et al. · 2013 [cited by applicant]
US 20130189333A1 · Gao et al. · 2013 [cited by applicant]
CN 1064594A · 1992 [cited by applicant]
CN 1207251A · 1999 [cited by applicant]
CN 1054884C · 2000 [cited by applicant]
CN 1498080A · 2004 [cited by applicant]
CN 1622758A · 2005 [cited by applicant]
CN 2720557Y · 2005 [cited by applicant]
CN 1903057A · 2007 [cited by applicant]
CN 1960648A · 2007 [cited by applicant]
CN 1961732A · 2007 [cited by applicant]
CN 1997350A · 2007 [cited by applicant]
CN 201156955Y · 2008 [cited by applicant]
CN 101861145A · 2010 [cited by applicant]
CN 101877975A · 2010 [cited by applicant]
CN 102300478A · 2011 [cited by applicant]
CN 102014654B · 2016 [cited by applicant]
EA 005421 · 2005 [cited by applicant]
EA 005626 · 2005 [cited by applicant]
EP 0118972A2 · 1984 [cited by applicant]
EP 0279776A2 · 1988 [cited by applicant]
EP 0288909A1 · 1988 [cited by applicant]
EP 1578422A2 · 2005 [cited by applicant]
EP 2226171A1 · 2010 [cited by applicant]
EP 2265263A2 · 2010 [cited by applicant]
EP 2804897A1 · 2014 [cited by applicant]
EP 2804498B1 · 2018 [cited by applicant]
JP 2007515950A · 2007 [cited by applicant]
JP 2010516243A · 2010 [cited by applicant]
RU 2291642C1 · 2007 [cited by applicant]
RU 2342846C2 · 2009 [cited by applicant]
WO WO8603102A1 · 1986 [cited by applicant]
WO WO9220307A1 · 1992 [cited by applicant]
WO WO200149124A1 · 2001 [cited by applicant]
WO WO2002076227A1 · 2002 [cited by applicant]
WO WO2002076230A1 · 2002 [cited by applicant]
WO WO2004068965A1 · 2004 [cited by applicant]
WO WO05046363A2 · 2005 [cited by applicant]
WO WO2006127772A2 · 2006 [cited by applicant]
WO WO2007095600A2 · 2007 [cited by applicant]
WO WO2007104574A2 · 2007 [cited by applicant]
WO WO2007104573A2 · 2007 [cited by applicant]
WO WO2008103935A2 · 2008 [cited by applicant]
WO WO2008133982A2 · 2008 [cited by applicant]
WO WO2009048522A1 · 2009 [cited by applicant]
WO WO2009114034A1 · 2009 [cited by applicant]
WO WO2011063338A2 · 2011 [cited by applicant]
WO WO2011139943A1 · 2011 [cited by applicant]
WO WO2012175085A1 · 2012 [cited by applicant]
WO WO2013109931A2 · 2013 [cited by applicant]
WO WO2013109961A1 · 2013 [cited by applicant]
United States Office Action for U.S. Appl. No. 17/211,128 dated Apr. 5, 2023 (6 pages). [cited by applicant]
Office Action dated Apr. 10, 2024 issued in related U.S. Appl. No. 17/752,706. [cited by applicant]
United States Office Action for corresponding U.S. Appl. No. 17/211,128 dated Dec. 28, 2022 (21 pages). [cited by applicant]
European Notice of Opposition Against European Patent No. 2804897, dated Apr. 13, 2017, 22 pages. [cited by applicant]
Extended European Search Report in European ApplicationNo. 16178530.8, dated Aug. 8, 2016. [cited by applicant]
List and Schmidt, “Medicinal leaves and herbs,” Phytopharmaceutical Technology 1989, p. 94. [cited by applicant]
Russian Office Action in Russian Application No. 2014134071, dated Jan. 26, 2017, 20 pages (with English translation). [cited by applicant]
Chinese Office Action in Chinese Application No. 201380014374.2, dated Jun. 2, 2016, 16 pages. [cited by applicant]
Chinese Office Action in Chinese Application No. 201380014374.2, dated Jan. 14, 2016, 14 pages (English translation only). [cited by applicant]
Dictionary of Chemistry and Chemical Technology, 2003, 4 pages (Chinese only). [cited by applicant]
Chinese Office Action in Chinese Application No. 201380014374.2, dated Jun. 18, 2015, 12 pages (English translation only). [cited by applicant]
Australian Office Action in Australian Application No. 2013204417, dated Dec. 5, 2014, 4 pages. [cited by applicant]
Chinese Office Action in Chinese Application No. 201210167508.1, dated Oct. 10, 2014, 2 pages. [cited by applicant]
Fibersol, http://www.fibersol.com/products/fibersol-2/, Oct. 2012. [cited by applicant]
International Preliminary Report on Patentability for PCT/US2013/022204 mailed Jul. 22, 2014, 12 pages. [cited by applicant]
International Preliminary Report on Patentability for PCT/US2013/022252 mailed Jul. 22, 2014, 9 pages. [cited by applicant]
Chinese Office Action in Chinese Application No. 201210167206.4, mailed May 22, 2014, 11 pages. [cited by applicant]
Second Chinese Office Action in Chinese Application No. 201210167332.X, mailed May 30, 2014, 5 pages. [cited by applicant]
Second Chinese Office Action in Chinese Application No. 201210167508.1, mailed May 30, 2014, 2 pages (English translation only). [cited by applicant]
Chinese Office Action in Chinese Application No. 201210167166.3, mailed May 22, 2014, 4 pages. [cited by applicant]
Chinese Office Action in Chinese Application No. 201210167508.1, mailed Dec. 4, 2013, 8 pages. [cited by applicant]
Chinese Office Action in Chinese Application No. 201210167234.6, mailed Jul. 19, 2013, 10 pages. [cited by applicant]
Chinese Office Action in Chinese Application No. 201210167332.X, mailed Dec. 4, 2013, 10 pages. [cited by applicant]
International Search Report and Written Opinion for PCT/US2013/022252 mailed Mar. 6, 2013, 12 pages. [cited by applicant]
International Search Report and Written Opinion for PCT/US2013/022204 mailed Dec. 16, 2013, 17 pages. [cited by applicant]
Krochta et al., “Edible and Biodegradable Polymer Films: Challenges and Opportunities,” Food Technology, 1997, 51:61-74. [cited by applicant]
Tso, Tobacco Production, “Seed to Smoke,” Chemistry and Technology, Blackwell Publishing, 1999, 1-31. [cited by applicant]
Office Action for corresponding Chinese Application No. 201380014655.8 dated Aug. 31, 2018, English translation thereof. [cited by applicant]
Observations in preparation for Oral Proceedings in Opposition Against EP Application No. 2804897 dated Aug. 17, 2018. [cited by applicant]
Recommendations for the characterization of porous solids, Pure & Appl. Chem., vol. 66, No. 8, pp. 1739-1758, 1994. [cited by applicant]
Porosity and Specific Surface Area Measurements for Solid Materials, P. Klobes, K. Meyer, R. Munro, NIST, Sep. 2006. [cited by applicant]
Petrophysics MSc Course Notes—Porosity, Dr. Paul Glover. [cited by applicant]
Evaluation of five methods for measuring mean fibre diameter of fleece samples from New Zealand sheep, R.N. Andrews, H. Hawker, S. F. Crosbie, New Zealand Journal of Experimental Agriculture, 15:1, 23-31, 1987. [cited by applicant]
Fibre Length, SGS Wool Testing Services, 2011. [cited by applicant]
Summons to Attend Oral Proceedings Pursuant to Rule 115(1) EPC dated Feb. 2, 2018. [cited by applicant]
Communication of Notices of Opposition (R.79(2) EPC) dated Jun. 6, 2017. [cited by applicant]
Response to Communication Pursuant to Rule 115(1) EPC, Opposition against EP2804897, dated Jun. 26, 2018. [cited by applicant]
Certified Copy of Priority Document dated Sep. 19, 2012. [cited by applicant]
Submission in Opposition Proceedings for application No. EP13702700.9 dated Oct. 16, 2017. [cited by applicant]
Microcrystalline Cellulose, 46th JECFA (1996). [cited by applicant]
Brief Communication for application No. EP13702700.9-1102 dated Jul. 2, 2018. [cited by applicant]
Responsive to the Summons to Attend Oral Proceedings pursuant to Rule 115(1) EPC dated Feb. 2, 2018 Based on PCT/US2013/022252 dated Jun. 28, 2018. [cited by applicant]
Pilot Spinning of Viscose Staple Fibres., Johanna Eriksson, Degree Project in Engineering Chemistry, Umea University, Dated May 2015. [cited by applicant]
Observations submitted in Opposition against EP2809897 dated Jun. 26, 2018. [cited by applicant]
Russian Office Action for corresponding Application No. 2014134071 dated Sep. 26, 2018 with English translation. [cited by applicant]
European Search Report for corresponding Application No. 18174632.2-1105 dated Nov. 7, 2018. [cited by applicant]
Chinese Final Office Action for corresponding Application No. 201710270107.1 dated Nov. 8, 2018. [cited by applicant]
United States Office Action for U.S. Appl. No. 15/816,506 dated Dec. 21, 2018. [cited by applicant]
Extended European Report for corresponding Application No. 18185575.0-1102 dated Dec. 20, 2018. [cited by applicant]
Canadian Office Action for corresponding Application No. 2,861,995 dated Dec. 7, 2018. [cited by applicant]
United States Office Action for corresponding U.S. Appl. No. 15/943,096 dated Feb. 8, 2019. [cited by applicant]
United States Office Action for corresponding U.S. Appl. No. 15/850,494 dated Apr. 2, 2019. [cited by applicant]
Notice of Opposition for corresponding European Application No. 16178530.8-1102/3098258, dated May 9, 2019. [cited by applicant]
United States Notice of Allowance for corresponding U.S. Appl. No. 15/943,096, dated Jun. 10, 2019. [cited by applicant]
Japanese Notice of Reasons for Rejection for corresponding Application No. 2018-032700, dated Jun. 3, 2019. [cited by applicant]
Canadian Office Action for corresponding Application No. 2,861,992, dated Jun. 14, 2019. [cited by applicant]
United States Office Action for corresponding U.S. Appl. No. 15/816,506, dated Jul. 12, 2019. [cited by applicant]
European Office Action for corresponding Application No. 18185575.0-1102, dated Sep. 5, 2019. [cited by applicant]
Canadian Office Action for corresponding Application No. 2,861,995, dated Sep. 6, 2019. [cited by applicant]
United States Office Action for U.S. Appl. No. 15/850,494, dated Oct. 1, 2019. [cited by applicant]
Food Applications, International Fiber Corporation, http:/ /buyersguide.supplysideshow.com/media /54 /library/49964- 313.pdf (Year:2010). [cited by applicant]
United States Office Action for U.S. Appl. No. 15/816,506, dated Oct. 25, 2019. [cited by applicant]
Chinese Reexamination Notice for corresponding Application No. 201710270107.1, dated Nov. 5, 2019. [cited by applicant]
United States Notice of Allowance for U.S. Appl. No. 15/943,096, dated Dec. 18, 2019. [cited by applicant]
United States Notice of Allowance for U.S. Appl. No. 15/850,494, dated Jan. 14, 2020. [cited by applicant]
United States Notice of Allowance for U.S. Appl. No. 15/816,506, dated Jan. 29, 2020. [cited by applicant]
European Office Action for corresponding Application No. 18174632.2-1105, dated Jan. 23, 2020. [cited by applicant]
European Office Action for corresponding Appliation No. 18185575.0-1102, dated Jan. 24, 2020. [cited by applicant]
United States Office Action for U.S. Appl. No. 16/592,978, dated May 26, 2020. [cited by applicant]
European Office Action for corresponding Application No. 18185575.0, dated Jun. 12, 2020. [cited by applicant]
United States Office Action for U.S. Appl. No. 16/592,978, dated Sep. 3, 2020. [cited by applicant]
European Office Action dated Nov. 11, 2020 for corresponding European Application No. 18185575.0. [cited by applicant]
U.S. Notice of Allowance dated Dec. 10, 2020 for corresponding U.S. Appl. No. 16/392,978. [cited by applicant]
U.S. Office Action for corresponding U.S. Appl. No. 16/840,820, dated Nov. 16, 2021 (24 pages). [cited by applicant]
United States Office Action for U.S. Appl. No. 16/881,627 dated Nov. 19, 2021. [cited by applicant]
United States Office Action for U.S. Appl. No. 16/840,820 dated Feb. 28, 2022 (12 pages). [cited by applicant]
United States Office Action for U.S. Appl. No. 16/808,844 dated Mar. 4, 2022 (12 pages). [cited by applicant]
United States Notice of Allowance for U.S. Appl. No. 16/881,627 dated Mar. 4, 2022. [cited by applicant]
Extended European Search Report for EP Application 21208338.0 dated Mar. 10, 2022 (8 pages). [cited by applicant]
Extended European Search Report for EP Application 212107593 dated Jul. 4, 2022 (8 pages). [cited by applicant]
Unites States Notice of Allowance for U.S. Appl. No. 16/840,820 dated Aug. 8, 2022 (10 pages). [cited by applicant]
United States Notice of Allowance for U.S. Appl. No. 16/808,844 dated Sep. 8, 2022 (9 pages). [cited by applicant]
European Office Action for EP Application 21208338.0 dated Feb. 27, 2023 (4 pages). [cited by applicant]
European Office Action for EP Application 21208338.0 dated Jul. 20, 2023 (3 pages). [cited by applicant]
United States Notice of Allowance for U.S. Appl. No. 17/211,128 dated Aug. 31, 2023 (8 pages). [cited by applicant]
United States Notice of Allowance for U.S. Appl. No. 17/752,706 dated Jul. 17, 2024 (7 pages). [cited by applicant]